
Results
11
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
11 companies
PharmaResearch
Market Cap: ₩4.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩393,000.00
7D
-5.8%
1Y
-41.8%
ST PharmLtd
Market Cap: ₩2.2t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩100,300.00
7D
-7.1%
1Y
12.2%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩117,200.00
7D
-9.9%
1Y
-11.9%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩36,600.00
7D
-2.1%
1Y
8.6%
Boryung
Market Cap: ₩774.7b
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
A003850
₩8,910.00
7D
-3.5%
1Y
7.3%
JW Holdings
Market Cap: ₩286.1b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩4,025.00
7D
-0.9%
1Y
20.7%
Chong Kun Dang Holdings
Market Cap: ₩195.2b
Manufactures and distributes pharmaceutical products in South Korea and internationally.
A001630
₩39,050.00
7D
-3.7%
1Y
-17.3%
Ilyang PharmaceuticalLtd
Market Cap: ₩155.8b
Operates as a pharmaceutical company primarily in South Korea.
A007570
₩8,360.00
7D
-7.0%
1Y
-34.5%
Sinsin Pharmaceutical
Market Cap: ₩68.9b
Manufactures and sells pharmaceutical products in South Korea.
A002800
₩4,540.00
7D
2.3%
1Y
-18.8%
RP Bio
Market Cap: ₩53.7b
A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.
A314140
₩5,990.00
7D
-6.8%
1Y
-8.5%
Korean Drug
Market Cap: ₩37.6b
Manufactures and sells medicines for treating various diseases in South Korea.
A014570
₩3,380.00
7D
-3.6%
1Y
-27.8%